Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observation
ConclusionsDiscontinuation of antiviral prophylaxis increased the risk of HBV reactivation in HBsAg-positive patients under immunotherapy for glomerulonephritis.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Glomerulonephritis | Hepatitis | Hepatitis B | Immunotherapy | Study | Urology & Nephrology